Literature DB >> 3758132

Light treatment in depressive illness. Polysomnographic, psychometric and neuroendocrinological findings.

M Dietzel, B Saletu, O M Lesch, W Sieghart, M Schjerve.   

Abstract

Objective and subjective quality of sleep and awakening as well as circadian rhythms in cortisol, temperature and well-being were investigated in 10 female hospitalized depressed patients diagnosed as major depressive disorders according to RDC criteria before (baseline), during (intervention) and after (recovery) treatment with biologically active or bright light (BL) and were compared with the findings in 10 normals. Polysomnographic evaluation demonstrated in depressed patients an increased sleep latency, decreased total sleep time, attenuated S4 and augmented REM sleep, as well as a shortened REM latency and a statistically significant increased average REM length as compared with normals. BL tended to shorten sleep onset, decrease number of awakenings, increase REM latency and significantly attenuated the average REM length. Subjective sleep quality tended to improve as did the subjective awakening quality after the recovery night. There was, however, a statistically significant improvement of the objectively evaluated quality of awakening and early morning behavior characterized by an improved attention, reaction time and performance in the reaction time task, while concentration and psychomotor activity tended to improve as as well. BL effects were also seen in hormonal secretion patterns: circadian cortisol secretion maxima occurred earlier in depressed patients than in normals before and after BL treatment, while during BL intervention this difference disappeared. Circadian temperature rhythms did not exhibit any significant findings with the exception of an earlier occurring minimum in depressed patients than in normals after treatment. Finally, subjective well-being as rated by means of an analogue scale was significantly worse in depressed patients than normals before but not during and after light treatment. The findings are discussed.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3758132     DOI: 10.1159/000116089

Source DB:  PubMed          Journal:  Eur Neurol        ISSN: 0014-3022            Impact factor:   1.710


  7 in total

Review 1.  Light therapy for non-seasonal depression.

Authors:  A Tuunainen; D F Kripke; T Endo
Journal:  Cochrane Database Syst Rev       Date:  2004

2.  The effect of adjunctive light therapy on ameliorating breakthrough depressive symptoms in adolescent-onset bipolar disorder.

Authors:  G Papatheodorou; S Kutcher
Journal:  J Psychiatry Neurosci       Date:  1995-05       Impact factor: 6.186

3.  Light treatment of mood disorders.

Authors:  Barbara L Parry; Eva L Maurer
Journal:  Dialogues Clin Neurosci       Date:  2003-12       Impact factor: 5.986

Review 4.  Somatic influences on subjective well-being and affective disorders: the convergence of thermosensory and central serotonergic systems.

Authors:  Charles L Raison; Matthew W Hale; Lawrence E Williams; Tor D Wager; Christopher A Lowry
Journal:  Front Psychol       Date:  2015-01-13

Review 5.  Circadian Rhythm Disturbances in Mood Disorders: Insights into the Role of the Suprachiasmatic Nucleus.

Authors:  Chelsea A Vadnie; Colleen A McClung
Journal:  Neural Plast       Date:  2017-11-05       Impact factor: 3.599

Review 6.  The Circadian Syndrome: is the Metabolic Syndrome and much more!

Authors:  P Zimmet; K G M M Alberti; N Stern; C Bilu; A El-Osta; H Einat; N Kronfeld-Schor
Journal:  J Intern Med       Date:  2019-06-10       Impact factor: 8.989

7.  Beneficial effects of daytime high-intensity light exposure on daily rhythms, metabolic state and affect.

Authors:  Carmel Bilu; Haim Einat; Paul Zimmet; Vicktoria Vishnevskia-Dai; Noga Kronfeld-Schor
Journal:  Sci Rep       Date:  2020-11-13       Impact factor: 4.379

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.